BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9399705)

  • 1. A semi-empirical approach to the evaluation of the relative biological effectiveness of therapeutic proton beams: the methodological framework.
    Belli M; Campa A; Ermolli I
    Radiat Res; 1997 Dec; 148(6):592-8. PubMed ID: 9399705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay.
    Wouters BG; Lam GK; Oelfke U; Gardey K; Durand RE; Skarsgard LD
    Radiat Res; 1996 Aug; 146(2):159-70. PubMed ID: 8693066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay.
    Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo simulations of therapeutic proton beams for relative biological effectiveness of double-strand break.
    Wang CC; Hsiao Y; Lee CC; Chao TC; Wang CC; Tung CJ
    Int J Radiat Biol; 2012 Jan; 88(1-2):158-63. PubMed ID: 21823821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical model estimation of relative biological effectiveness for proton beam therapy.
    Chen Y; Ahmad S
    Radiat Prot Dosimetry; 2012 Apr; 149(2):116-23. PubMed ID: 21593038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of relative biological effectiveness for proton beams using biological weighting functions.
    Paganetti H; Olko P; Kobus H; Becker R; Schmitz T; Waligorski MP; Filges D; Müller-Gärtner HW
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):719-29. PubMed ID: 9112472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
    Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
    Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
    Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning.
    Elsässer T; Weyrather WK; Friedrich T; Durante M; Iancu G; Krämer M; Kragl G; Brons S; Winter M; Weber KJ; Scholz M
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1177-83. PubMed ID: 20732758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproton radiotherapy.
    Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
    Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiological intercomparison of the 160 MeV and 230 MeV proton therapy beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital.
    Wouters BG; Skarsgard LD; Gerweck LE; Carabe-Fernandez A; Wong M; Durand RE; Nielson D; Bussiere MR; Wagner M; Biggs P; Paganetti H; Suit HD
    Radiat Res; 2015 Feb; 183(2):174-87. PubMed ID: 25587741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative biological effectiveness of proton medical beam at Moscow synchrotron determined by the Chinese hamster cells assay.
    Yashkin PN; Silin DI; Zolotov VA; Kostjuchenko VI; Nichiporov DF; Feoktistova TP; Martirosov KS; Minakova YI; Khoroshkov VS; Polonski PB
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):535-40. PubMed ID: 7852117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological effectiveness of antiproton irradiation.
    Holzscheiter MH; Bassler N; Agazaryan N; Beyer G; Blackmore E; DeMarco JJ; Doser M; Durand RE; Hartley O; Iwamoto KS; Knudsen HV; Landua R; Maggiore C; McBride WH; Møller SP; Petersen J; Skarsgard LD; Smathers JB; Solberg TD; Uggerhøj UI; Vranjes S; Withers HR; Wong M; Wouters BG
    Radiother Oncol; 2006 Dec; 81(3):233-42. PubMed ID: 17069916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak.
    Petrović I; Ristić-Fira A; Todorović D; Korićanac L; Valastro L; Cirrone P; Cuttone G
    Int J Radiat Biol; 2010 Sep; 86(9):742-51. PubMed ID: 20597839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effectiveness of (12)C and (20)Ne ions with very high LET.
    Czub J; Banaś D; Błaszczyk A; Braziewicz J; Buraczewska I; Choinski J; Gorak U; Jaskoła M; Korman A; Lankoff A; Lisowska H; Lukaszek A; Szeflinski Z; Wojcik A
    Int J Radiat Biol; 2008 Oct; 84(10):821-9. PubMed ID: 18979317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative biological effectiveness of high-energy iron ions for micronucleus formation at low doses.
    Groesser T; Chun E; Rydberg B
    Radiat Res; 2007 Dec; 168(6):675-82. PubMed ID: 18088180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo simulation and polymer gel dosimetry of 60 MeV clinical proton beams for the treatment of ocular tumours.
    Baker CR; Quine TE; Brunt JN; Kacperek A
    Appl Radiat Isot; 2009 Mar; 67(3):402-5. PubMed ID: 18691897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.